Leerink Partners analyst Whit Mayo reiterated a Buy rating on Ardent Health Partners, Inc. today and set a price target of $16.00.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Whit Mayo has given his Buy rating due to a combination of factors including the current valuation of Ardent Health Partners, Inc. and the potential for cost savings initiatives. Despite the recent quarterly results revealing some unexpected challenges, such as increased payer denials and professional fees, Mayo believes the market’s reaction was excessively negative. The company’s stock is trading at historically low valuation multiples, which Mayo views as an opportunity given the potential for stabilization and improvement in earnings.
Furthermore, Mayo notes that demand remains robust, with strong volume growth in admissions and surgical procedures, indicating a resilient core business. The anticipated cost savings from recent initiatives are expected to offset some of the financial pressures, providing a more favorable outlook for the future. These factors contribute to Mayo’s confidence in the company’s ability to navigate current challenges and deliver value to shareholders, justifying the Buy rating.
Mayo covers the Healthcare sector, focusing on stocks such as Ardent Health Partners, Inc., HCA Healthcare, and Tenet Healthcare. According to TipRanks, Mayo has an average return of 4.3% and a 53.09% success rate on recommended stocks.
In another report released today, RBC Capital also maintained a Buy rating on the stock with a $16.00 price target.